Oral fingolimod for chronic inflammatory demyelinating polyradiculoneuropathy (FORCIDP Trial): a double-blind, multicentre, randomised controlled trial
- Resource Type
- Article
- Authors
- Day, Timothy; Spies, Judith; Roberts, Leslie; Van Damme, Philip; Van den Bergh, Peter YK; Maertens de Noordhout, Alain; Dionne, Annie; Larue, Sandrine; Massie, Rami; Melanson, Michel; Camu, William; De Seze, Jérôme; Le Masson, Gwendal; Pouget, Jean; Schmidt, Jens; Kimiskidis, Vasilios K; Chapman, Joab; Drory, Vivian E; Fazio, Raffaella; Gallia, Francesca; Kusunoki, Susumu; Mori, Masahiro; Iijima, Masahiro; Okamoto, Tomoko; Baba, Masayuki; Faber, Catharina G; van Schaik, Ivo N; Fryze, Waldemar; Motta, Ewa; Selmaj, Krzysztof; Casasnovas, Carlos; Sola, Antonio Guerrero; Illa, Isabel; Holt, James; Miller, James AL; Lunn, Michael P; Brannagan, Thomas H, III; Brown, Martin; Kelemen, John; Iyadurai, Stanley; Rezania, Kourosh; Sharma, Khema R; Tandan, Rup; Gudesblatt, Mark; Lawson, Victoria; Amato, Anthony A; Hughes, Richard; Dalakas, Marinos C; Merkies, Ingemar; Latov, Norman; Léger, Jean-Marc; Nobile-Orazio, Eduardo; Sobue, Gen; Genge, Angela; Cornblath, David; Merschhemke, Martin; Ervin, Carolyn Marie; Agoropoulou, Catherine; Hartung, Hans-Peter
- Source
- In The Lancet Neurology August 2018 17(8):689-698
- Subject
- Primary Research
Articles
- Language
- ISSN
- 1474-4422